Encoded Therapeutics Inc. Funding & Investors
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad range of severe genetic disorders. The company's therapy pipeline addresses devastating genetic and acquired disorders spanning multiple disease pathways including neurocircuitry, metabolic disorders, neurodegeneration and cardiovascular disease, enabling medical practitioners to treat patients and improve their lives.
encoded.comTotal Amount Raised: $239,100,000
Encoded Therapeutics Inc. Funding Rounds
Series D
$135,000,000
Series D Investors
RTW InvestmentsIllumina VenturesMenlo VenturesNolan CapitalSoftBank Investment AdvisersMatrix Capital ManagementArch Venture PartnersGreen Sands EquityGVBoxer CapitalMeritech Capital PartnersFarallon Capital ManagementSeries C
$104,000,000
Series C Investors
RTW InvestmentsIllumina VenturesMenlo VenturesAltitude Life Science VenturesMatrix Capital ManagementVenrockArch Venture PartnersAlexandria Venture InvestmentsBoxer CapitalConvertible Note
$100,000
Convertible Note Investors
Illumina Accelerator
Funding info provided by Diffbot.